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Using Growth Mixture Modeling to Identify Classes of Sodium
Adherence in Adults with Heart Failure
Abstract
BACKGROUND: The prevention of fluid retention is important to reduce hospitalizations in patients with
heart failure (HF). Following a low-sodium diet helps to reduce fluid retention.
OBJECTIVE: The primary objective of this study was to use growth mixture modeling to identify distinct
classes of sodium adherence-characterized by shared growth trajectories of objectively measured dietary
sodium. The secondary objective was to identify patient-level determinants of the nonadherent trajectory.
METHODS: This was a secondary analysis of data collected from a prospective longitudinal study of 279
community-dwelling adults with previously or currently symptomatic HF. Growth mixture modeling was
used to identify distinct trajectories of change in 24-hour urinary sodium excretion measured at 3 time points
over 6 months. Logistic modeling was used to predict membership in observed trajectories.
RESULTS: The sample was predominantly male (64%), had a mean age of 62 years, was functionally
compromised (59% New York Heart Association class III), and had nonischemic HF etiology. Two distinct
trajectories of sodium intake were identified and labeled adherent (66%) and nonadherent (34%) to low-
sodium diet recommendations. Three predictors of the nonadherent trajectory were identified, confirming our
previous mixed-effect analysis. Compared with being normal weight (body mass index/m2), being
overweight and obese was associated with a 4-fold incremental increase in the likelihood of being in the
nonadherent trajectory (odds ratio [OR], 4.63; 95% confidence interval [CI], 1.66-12.91; P < .002). Being
younger than 65 years (OR, 4.66; 95% CI, 1.04-20.81; P = .044) or having diabetes (OR, 4.15; 95% CI,
1.29-13.40; P = .016) were both associated with more than 4 times the odds of being in the nonadherent urine
sodium trajectory compared with being older than 65 years or not having diabetes, respectively.
CONCLUSIONS: Two distinct trajectories of sodium intake were identified in patients with HF. The
nonadherent trajectory was characterized by an elevated pattern of dietary sodium intake shown by others to
be associated with adverse outcomes in HF. Predictors of the nonadherent trajectory included higher body
mass index, younger age, and diabetes.
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Introduction
Adherence to a low-sodium diet is an important self-care behavior for patients with heart
failure (HF). Excess sodium intake promotes higher ventricular filling pressures, pulmonary
congestion, clinical symptoms of fluid retention, and puts patients with HF at high risk for
acute decompensation and hospitalizations. 1 As such, adherence to a low-sodium diet is a
key factor in reducing hospitalizations2 and one of the most frequently recommended self-
care behaviors. 3-6 Both the 2012 European Society of Cardiology and 2009 American
College of Cardiology/American Heart Association guidelines recommend less than 2 g/day
of dietary sodium. 7,8 Likewise, the Heart Failure Society of America recommends that all
patients with clinical symptoms of HF restrict sodium to 2-3 g/day. 6 It is estimated,
however, that only about 22-55% of HF patients are adherent to a low-sodium diet. 9-12
Adherence, as defined by the World Health Organization (WHO), is a multidimensional
phenomenon, determined by multiple dimensions related to social and economic conditions,
the health care system in addition to condition, therapy or patient-related factors.13 Like
medication adherence in this patient population, adherence to a low sodium diet is
influenced by a number of factors.14 Although several factors have been associated with
non-adherence to a low-sodium diet in the adult population with HF, there are limitations to
these research findings. Most prior studies on 24-hour urine sodium excretion are cross-
sectional in design and conducted with small samples. Deterministic methods, including
mixed effects modeling have previously been used to identify patient-level factors
associated with high sodium intake using an a priori determined cutoff of adherence.15 This
study builds on that analysis by applying a growth mixture modeling methodology to
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identify the “most likely” trajectory membership and quantify uncertainty in trajectory
membership over time.
The specific aim of this study was to use growth mixture modeling to identify distinct
patterns of change in 24-hour urine sodium excretion, as a proxy for dietary sodium intake,
over six months of observation. The secondary aim was to build on a previous mixed effects
analysis15 and examine patient-level determinants of observed trajectories of urine sodium.
Methods
Design and Study population
The methodology of this study has been previously reported in detail. 14 In brief, this was a
prospective, observational study of the association between excessive daytime sleepiness
and HF self-care among 279 community-dwelling adults with chronic HF. The participants
were enrolled from three outpatient settings in Philadelphia, Pennsylvania and Newark,
Delaware between 2007 and 2010. Most of the participants were followed in specialty HF
clinics and most were on optimal medical therapy. Given the observational nature of this
study, the usual care provided by HF specialty clinics was not augmented. Participants did
not receive supplemental HF self-care education outside of what was provided as part of
routine care.
Inclusion criteria for the study specified adults with previously or currently symptomatic HF
confirmed by echocardiographic and clinical evidence. 14 The participants needed to be able
to actively participate in the study, so inclusion criteria specified that patients must be able
to read and speak English and have sufficient cognition and health literacy to complete the
questionnaires. Otherwise eligible individuals were excluded if they lived in a long-term
care setting and were not responsible for their own self-care, including preparing and
making choices about food. People were also excluded if they had renal failure requiring
dialysis, imminent plans to move out of the area, a history of drug or alcohol abuse within
the past year or an imminently terminal illness. People with major depressive illness were
also excluded because self-care behaviors are influenced by major depression. 16 This study
was in compliance with the Declaration of Helsinki. 17 Institutional Review Board approval
was obtained from all three sites and all participants gave written informed consent. Data
were collected at baseline, 3-and 6-months by research assistants during home visits.
Institutional Review Board approval was obtained for this secondary analysis.
Measurement of dietary sodium
A 24-hour urine sodium collection is considered a reliable and valid estimate of sodium
intake 18,19 and has been used as an objective measure of sodium intake in other studies with
patients with HF. 1,20 Sodium is under tight homeostatic control. If individuals do not
perspire heavily, urine sodium accounts for approximately 95% to 98% of daily dietary
sodium intake. 21 Variations in 24-hour urine sodium are primarily attributed to changes in
sodium intake over the previous 24 hours.22 Daily urine sodium levels are estimated to
fluctuate only about 11%. 23 Validation for 24-hour urine collection has been performed by
urine recovery of oral doses of para-amino benzoic acid.19,23,24
The methodology for collecting and measuring dietary sodium intake has been reported
elsewhere 15 and is summarized here. Dietary sodium intake was estimated using three 24-
hour urine sodium levels measured at enrollment, and at three and six months after
enrollment. The procedure for the collection and quantification of the 24-hour urine samples
is summarized here. At the time of enrollment, participants and their family members were
given training for the specimen collection. Participants were provided with all necessary
supplies including: urine containers, collection devices, verbal and written instructions (with
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pictures) specifying when they should start and finish collecting the specimen. Prior to each
urine collection, patients were given a reminder call and training for the procedure was
reinforced by the research assistant. Participants self-reported the start and stop time of the
urine collection. If the recorded time was less than 22 hours or greater than 26 hours it was
considered inaccurate and excluded from the analysis. Specimens were collected from
participant's homes by a courier service shortly after the 24-hour sample was complete.15
Urine sodium analyses were completed at the central laboratory at the Hospital of the
University of Pennsylvania using the ion-selective electrode method (Beckman LX® 20
Chemistry Analyzer, Beckman Coulter, Inc., Fullerton, CA) to determine the amount of
sodium in the urine specimens. A normal urinary sodium level is 40 to 120 mEq/L/day. 11 In
order to compare urine excretion with the recommended diet of 2-3 g/day sodium intake, 6
urine sodium excretion in millimoles was converted to g (g= mmol* .02299) to estimate
dietary sodium intake. As a quality assurance measure, urinary creatinine was measured
concurrently. Normal urinary creatinine is 1 ± 10% g 25 so any samples with creatinine
levels <0.9 g in 24 hours were considered incomplete.26
Statistical Analysis
Standard descriptive (proportions, means and standard deviations), unadjusted odds ratios
and t tests were used to describe the sample and compare trajectories. Latent growth mixture
modeling was used to identify distinct trajectories of urinary sodium using data from three
time points.
Latent class growth modeling is used to examine patterns in longitudinal data with repeated
measures to identify classes or subgroups within a population. Unique trajectories or
pathways differentiate classes from one another. Using repeated measures to identify
subgroups within a population has been used across multiple disciplines. Latent class growth
mixture analysis also has been used across multiple disciplines to identify trajectories of
development; 27 nighttime continence;28 physical aggression in young boys;29 the natural
history of prostate disease;30 depression recovery profiles31 and preventative interventions
for reducing classroom violence. 32 It has also been used extensively in the substance abuse
literature to identify trajectories and predictors of high-risk behavior.33-44 Within the heart
failure literature, it has been used to identify patterns of cognitive change,45 as well as
patterns of medication nonadherence. 46
The purpose of growth mixture modeling is to identify homogenous subgroups within larger
heterogeneous populations and represent unobserved heterogeneity among subjects in a
sample. Finite mixture random effects are used to represent the departure of individuals'
latent growth parameters from the population mean growth parameter. 32,47 Class
membership of an individual cannot be measured directly; however, it can be inferred based
on membership in a specific trajectory.48 According to Wang and colleagues growth mixture
modeling can be described as having three steps. The first step is analogous to random
effects modeling which specifies individual-level observed data as a sum of fixed effects,
random effects and measurement errors at each observation point. 48 The second step
represents the distribution of class-specific random effects and covariate effects on class-
specific mean growth trajectories. The third step includes the covariate effects on class
membership using regression models. 48
Growth mixture modeling has many benefits over alternative methods, as reviewed by
Preacher.49 Growth mixture modeling can model changes in factors over time as random
effects, allow for variations between individuals and subgroups (instead of individuals and
the population average as in mixed-effect modeling) and judge comparative fit between
iterative models with various statistics; the focus of growth mixture modeling is on
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capturing inter-and-intra-individual differences over time.50 Conventional deterministic
approaches minimize within group and maximize between-group variance. In contrast,
growth mixture modeling employs a model-based approach to calculate the probability of
membership in each trajectory, identify “most likely” trajectory membership, and quantifies
uncertainty in trajectory membership. In this article the terms subgroups and classes are used
synonymously to describe people who share a specific growth trajectory.
Growth mixture modeling was performed using MPlus v.6.12 (Los Angeles, CA). Model fit
between 2 to 4 trajectories were compared (k vs k-1 trajectories) using the Lo-Mendell-
Rubin adjusted likelihood ratio test (p<0.05), parametric bootstrapped likelihood ratio test
(p<0.05), Bayesian Information Criteria (BIC), convergence (entropy closest to 1.0), the
proportion of the sample in each trajectory (not less than 5%), and average posterior
probabilities (closest 1.0). 50,51 Predictors of observed trajectories of dietary sodium were
quantified using logistic regression modeling in MPlus. Unadjusted and multivariate odds
ratios (OR) and 95% confidence intervals (CI) were calculated for each model factor, taking
into account our method of multiple imputation, described below.
The following ten determinants of non-adherence were tested based on the five dimensions
of adherence posed by the WHO.52 Four of the five WHO adherence dimensions were
included in this analysis. The fifth factor was not included because data on the health care
system was not available for this secondary data analysis. Patient related factors included
gender, age and BMI. Social and economic factors included race, income and highest level
of education. Condition related factors included New York Heart Association (NYHA)
functional class, HF type (diastolic or systolic), etiology of HF and diabetes as a
comorbidity. Therapy related included diuretic use.
Robust Handling of Missing Data
In an effort to reduce bias, a principled method of multiple imputation53 was performed to
account for missing urine sodium excretion values (23% of the sample had at least one
missing value). Data were imputed using the method of chained equations (Stata v.
11.2). 54-56 The method of chained equations is a contemporary technique that imputes
missing data based on multiple covariates in the dataset (i.e. a full information method of
imputation). The latent class variable was fit on imputed data in Mplus v.6.12. Multiple
sensitivity analyses were performed to examine potential differences in the significance and
effect size of predictors of urine sodium trajectories comparing complete case with imputed
data samples. There were no differences in the predictors identified in the models except for
the size of the confidence intervals; thus, for economy of presentation, only the final
analysis using imputed data is shown here.
Results
The overall demographic and clinical characteristics of the sample population overall at
baseline are presented in Table 1. This sample of adults (n=279) with HF was predominantly
male (64%), had a mean age of 62, non-ischemic HF etiology and was functionally
compromised (59% NYHA class III). The unadjusted odds ratios for the analysis are
presented in Table 2. The covariates that had a statistically significant unadjusted association
with the non-adherent trajectory were diabetes (p=0.008), income (p=0.031) and BMI
(p<0.001).
Modeling of three and four trajectories resulted in poor model fit and small trajectories (data
not shown). Entropy for the two-class model was 0.752 and there were high average
posterior probabilities of membership in both trajectories (94% and 91%), indicating very
limited uncertainty in trajectory membership. Based on the observed characteristics, we
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labeled the first and largest trajectory “adherent” (n=178, 66%) and second trajectory “non-
adherent” (n=91, 34%).
As displayed in the Figure there was heterogeneity within each trajectory, as demonstrated
by the error bars, which indicate two standard deviations around each mean urine sodium
level at each point in time. Paired t-tests demonstrate statistically significant differences
between the two trajectories at each time point (p<0.001). Those in the adherent group
started off at baseline with a mean sodium consumption of 2.42 g/day (standard deviation
(SD) ±0.19, 95% CI: 2.39-2.45) versus 4.41 g/day (SD: ±0.34, 95% CI: 4.33-4.48) in the
non-adherent trajectory (t=61.68, p<0.001). At three months, the mean difference between
the two trajectories was 2.16 g/day (SE: 0.36, t=59.99, p<0.001) and by six months was 1.98
g/day (SE: ±0.03, t=62.56, p<0.001). Within the adherent and non-adherent trajectories there
were no differences from baseline to 6 months (SE: ±0.02, t= -1.39, p=0.166 and SE: ±0.05,
t= -0.47, p=0.640), indicating that there were limited changes in dietary sodium intake over
time.
Based on the WHO model, predictors of membership in the non-adherence trajectory were
identified. The conceptual model was also supported using data driven statistical approaches
including univariate associations. Compared with normal weight patients (BMI <25), being
overweight and obese was associated with a 4-fold incremental increase in the likelihood of
being in the non-adherent trajectory (OR: 4.63, 95% CI: 1.66-12.91, p<0.002). Being less
than 65 years of age (OR: 4.66, 95% CI: 1.04-20.81, p=0.044) or having diabetes (OR: 4.15,
95% CI: 1.29-13.40, p=0.016) were both associated with over four times the odds of being
in the non-adherent urine sodium trajectory compared with people who are over 65 or do not
have diabetes, respectively. There were no significant differences in the odds of being in the
non-adherent trajectory based on gender, cognition, diuretic use, income level, education,
race, HF etiology, HF type or NYHA functional status.
Discussion
The primary aim of this study was to identify trajectories of sodium adherence in a sample
of community dwelling HF patients and two groups were identified. Based on the more
liberal Heart Failure Society of America sodium recommendations of 3g/day sodium
intake, 6 one trajectory was labeled “adherent” and the other “non-adherent” to a low sodium
diet. Both groups were consistently adherent or non-adherent over six months of follow-up.
That is, there was no change in the level of adherence or non-adherence over time.
To the best of our knowledge, this is the first study that describes adherence to a low-sodium
diet using a growth mixture approach; however, this method has been applied to medication
adherence in this study sample. 46 The predictors of the non-adherence to a low sodium diet
were being overweight or obese, age less than 65 years and having diabetes. These results
that obesity and diabetes predict higher sodium consumption are consistent with an analysis
that employed a mixed-effect analytic approach;15 however, in this study we also identified
younger age as a risk factor for being non-adherent to a sodium restricted diet.
HF patients who were overweight or obese, age less than 65 years or have diabetes were
identified as being more likely to have trouble following a restricted sodium diet and may
need more focused, tailored self-care interventions.57 One approach to tailoring self-care
interventions that we are testing in a pilot randomized control study is a tailored
motivational interviewing and skill-building approach to improving self-care behaviors
including adherence to a low-sodium diet.
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The finding that being obese is strongly associated with greater odds of being non-adherent
to a restricted sodium diet implies that these patients may be consuming more food and by
default more sodium, or that they are specifically consuming more foods that are higher in
sodium. This finding is consistent with the Intersalt international study of electrolyte
excretion and blood pressure, in which investigators reported a positive correlation between
BMI and sodium excretion.19 They proposed that overweight individuals consuming higher
sodium intake most likely explains this finding. 58 In contrast, Chung et al 20 found no
differences in BMI between people who self-reported being adherent or non-adherent to
low-sodium guidelines. The approach in our study is different than that used by Chung and
colleagues in that we did not apply a 2,000 mg cutoff for sodium adherence. Instead, we
identified distinct and naturally occurring trajectories of urinary sodium excretion that
happened to track with current dietary sodium recommendations. Moreover, the current
study was longitudinal in design. Thus, methodological differences may explain our
incongruent findings.
Other authors studying sodium adherence in the HF population have not reported our finding
of an association between younger age and non-adherence to a low sodium diet. In studies of
adherence to self-maintenance behaviors, an association between age and adherence to
medication has been reported. Several studies report that younger patients are more adherent
to taking medication 59,60 while others found no consistent difference in medication
adherence by age. 61-63 In this specific sample, we found no difference in overall medication
adherence by age. 64 The association with younger age and the non-adherent trajectory could
be that younger patients with HF may also be more newly diagnosed and not yet adept in the
skills of identifying and avoiding hidden sodium in foods. Patients with HF who are over 65
years may be living that long because they have been more stringent with the self-
maintenance behavior of eating a low salt diet.
The finding that diabetes is a strong predictor of the non-adherence to a low sodium diet is
most likely explained by overconsumption of sodium, rather than a physiologic mechanism.
In fact, in the diabetic state of hyperinsulinemia, sodium reabsorption is enhanced in the
nephron segments of the kidney. 65-68 Clinically, patients with both HF and diabetes may
struggle to closely monitor both their sugar and their sodium intake. There may receive
conflicting messages from multiple providers about nutritional priorities. The implications
of this finding may be that interventions are needed to specifically address the dietary
complexities of managing both HF and diabetes in this patient population.
Several factors that we anticipated would predict sodium adherence did not reach statistical
significance, including higher income and education. We expected that people who reported
having inadequate income would potentially be more likely to be non-adherent to a low
sodium diet because low-sodium food is more expensive and time consuming to prepare
than processed, higher-sodium foods; however, there were no differences between people
who reported more income than needed, enough to meet needs or less than needed. Several
investigators have suggested that people with more years of education would be more
adherent with medication; 62,69 however, education has not been found to be associated with
sodium adherence. In this study, we found no differences in sodium adherence based on
education. The lack of association between years of education and adherence to low-sodium
diet is consistent with the propositions of the WHO adherence model,13 which suggests that
higher education in and of itself does not necessarily lead to higher health literacy or
behavior change. In this specific study, poor health literacy was an exclusion criterion. As an
observational study, there was also no intervention tested, limiting our ability to comment on
behavior change.
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There are probably many other barriers to following a low-sodium diet that are more
important than knowledge. For instance, an identified barrier for patients is the perception
that foods will taste bland and unappealing without added salt.57 This barrier has been
addressed by clinicians who promote flavoring with salt substitutes, using low-sodium cook
books and allowing taste buds to adapt to lower-sodium foods.70 Other contextual barriers
identified in a qualitative descriptive study of older women with hypertension and HF
include eating alone with no motivation to cook healthy meals. These women also identified
that healthcare providers need to provide more education on a low-sodium diet, as well as
large-print informational materials.71 A study by De Brito-Ashurt (2011) identified barriers
to dietary sodium restriction in people of Bangladeshi origin with chronic renal disease
living the UK.72 Though the disease and patient population are different from this study
population, the barriers, including deeply rooted dietary beliefs, attitudes and culturally
established taste for salt,72-74 are likely to be universal across patient populations.
Other authors found low-sodium diet adherence rates to be about 28% or 29%. 11,12 The
findings from this study offer a different perspective from that of population-average
adherence. What we can say is that 66% of the sample fit the adherent profile to sodium
recommendations and 34% fit the non-adherent profile. These numbers cannot be compared
with other population averages or direct calculations of sodium adherence. This non-
deterministic approach offers advantages to understanding how non-adherence can be
examined and provides a list of useful predictors that are relevant to clinicians for tailoring
self-care interventions and education.
Strengths and Limitations
The primary strength of this study is the use of growth mixture modeling, which enables
moving away from quantifying the overall population average to examining and quantifying
heterogeneity and identifying distinct subgroups. Another strength of this research is that it
includes longitudinal data collected at three time points, on a relatively large group of
community dwelling stable patients with HF. Many other studies that have examined sodium
adherence included only one, 24-hour urine collection in small sample sizes. With an even
larger sample size, we may have been able to identify more latent categories of adherence
and more predictors of trajectory membership. Further research is needed to determine if the
two classes identified in this study will hold across multiple populations of patients with HF.
In other words, are these predictors consistent and generalizable to different populations of
patients with HF, or localized findings? The primary limitation of this dataset was that
originally 23% of the total sample had missing outcome data; however, this was accounted
for, at least in part, by contemporary and robust imputation techniques.
Conclusion
Two distinct trajectories of sodium intake were identified. The non-adherent trajectory
identifies a distinct pattern of dietary sodium intake that is not consistent with current
sodium guidelines. Identified predictors (overweight or obese, less than 65, or having
diabetes) can be used by clinicians to target interventions to patients who are most likely to
struggle with eating a lower sodium diet. Results can also be used to tailor interventions and
patient education programs to the highest risk groups. They can also be incorporated into HF
management programs. Future studies identifying the specific barriers within these patient
populations are also warranted so that the specific barriers can be targeted with
interventions.
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Figure.
Trajectories of adherence to low sodium diet recommendations for patients with heart failure
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Table 1
Characteristics of the overall sample at baseline (n=279)
Overall n (%) Overall n (%)
Age Diuretic
 < 65 years 165 (59)  Yes 225 (81)
 >=65 years 114 (41)  No 54 (19)
Gender Cognitive Impairment* (n=271)
 Male 179 (64)  Yes 107 (40)
 Female 100 (36)  No 164 (61)
Race Heart failure type
 Black/Other 104 (38)  Diastolic/Mixed 86 (31)
 White 175 (63)  Systolic 193 (69)
Income Body mass index * (n=278)
 More than needed 98 (35)  Normal 74 (26)
 Enough to meet needs 137 (49)  Overweight 73 (26)
 Less than needed 44 (16)  Obese 131 (47)
NYHA functional class Highest level of education
 Class I+II 65 (23)  Less than high school 27 (10)
 Class III 164 (59)  High school graduate 102 (37)
 Class IV 50 (18)  More than high school 150 (54)
Heart failure etiology Diabetes
 Ischemic HF 102 (37)  Yes 171 (61)
 Non-ischemic HF 177 (63)  No 108 (39)
Hypertension COPD
 Yes 180 (65)  Yes 58 (21)
 No 99 (35)  No 221 (79)
NYHA = New York Heart Association, COPD = Chronic obstructive pulmonary disease
*Variables containing missing data
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Table 2
Unadjusted odds of membership in the non-adherent urine sodium trajectory (n=279)
Unadjusted Odds Ratio 95% CI p-value
Gender
 Female (reference)
 Male 1.51 0.57-4.03 >0.2
Body Mass Index
 Normal (reference)
 Overweight 5.27 2.23-13.06 <0.001
Age
 >=65 years (reference)
 < 65 years 4.80 0.45-51.80 0.20
Diabetes
 No (reference)
 Yes 3.71 1.41-9.80 0.008
Race
 White (reference)
 Black/Other 2.60 0.97-7.00 0.059
Income 2.07 1.07-4.02 0.031
NYHA Functional Class 1.27 0.69-2.37 >0.20
Heart failure etiology 1.57 0.37-6.68 >0.20
Heart failure type 2.68 0.89-8.03 0.078
Diuretic 3.58 0.35-36.62 >0.20
Cognitive Impairment* n=271 1.00 0.44-2.27 >0.20
LVEF *n=278 0.99 0.97- 1.00 0.089
CI = confidence intervals, NYHA = New York Heart Association, LVEF = Left Ventricular Ejection Fraction
*Variables containing missing data
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Table 3
Identifying predictors of non-adherence to the low-sodium dietary recommendation using multivariate logistic
regression modeling (n=270)
Odds Ratio 95% CI p-value
Gender
 Female (reference)
 Male 3.52 0.93-13.26 0.063
Body Mass Index
 Normal (reference)
 Overweight 4.63 1.66-12.91 0.002**
Age
 >=65 years (reference)
 < 65 years 4.66 1.04-20.81 0.044**
Diabetes
 No (reference)
 Yes 4.15 1.29-13.40 0.016**
Race
 White (reference)
  Black/Other 1.20 0.28-5.15 >0.20
Income 0.95 0.33-2.75 >0.20
NYHA Functional Class 0.71 0.43-1.17 >0.20
Heart failure etiology 1.51 0.39-5.86 >0.20
Heart failure type 1.27 0.28-5.80 >0.20
Diuretic 1.18 0.15-9.02 >0.20
Cognitive Impairment 0.65 0.21-2.04 >0.20
LVEF 0.99 0.96-1.03 >0.20
CI = confidence intervals, NYHA = New York Heart Association, LVEF = Left Ventricular Ejection Fraction
**Statistically significant p<0.05
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